For overseas participant

General Information

The 11th Annual Meeting of the Japanese Pulmonary Circulation and Pulmonary Hypertension Society with the 6th East Asia Society of Pulmonary Hypertension (EASOPH)

Theme

Towards Integration of Pulmonary Hypertension Care, Research, and Education
– A Journey from Fetus to Adult, expanding from Asis to the World –

Date

May 30th-31st, 2026
EASOPH: May 30th, 2026

Venue

Kobe International Conference Center, Hyogo, Japan

President

Yoshihiro Fukumoto, MD, PhD (Kurume University, Fukuoka, Japan)

Congress President

Shigetoyo Kogaki, MD (Osaka General Medical Center, Osaka, Japan)

Congress Vice President

Takeshi Ogo, MD, PhD (National Cerebral and Cardiovascular Center, Osaka, Japan)
Tohru Takeuchi, Md, PhD (Osaka Medical and Pharmaceutical University, Osaka, Japan)
Yoshikazu Nakaoka, MD, PhD (National Cerebral and Cardiovascular Center, Osaka, Japan)
Osamu Nishiyama, MD, PhD (Kindai University, Osaka, Japan)

Advisor

Keiko Yamauchi-Takihara, MD, PhD (The University of Osaka, Osaka, Japan)

Secretary General

Hidekazu Ishida, MD, PhD (The University of Osaka, Osaka, Japan)

Congress Secretariat

Medical Qol Co., Ltd
E-mail: 11jpcphs@m-qol.co.jp

Access

Kobe International Conference Center
https://kobe-cc.jp/en/visitors/access/

Abstract Submission

Call for Abstract Period

November 20th, 2025 to January 20th, 2026 (JST)

Type of Presentation

Oral Presentation

Conflict of Interest (COI)

The Japanese Pulmonary Circulation and Pulmonary Hypertension Society (JPCPHS) requires Invited speakers, and lead presenter for oral presentations to disclose financial relationships related to the presentations for the past 3 years on the occasion of their presentations.

Please check the Criteria of COI below;
  1. Leadership position or advisory role for a company or for-profit organization: annual remuneration of ¥1 million or more from a single company or organization for 1 year
  2. Stockholder: profits (total of dividends and profits on sale of shares) of ¥1 million or more for 1 year from the stock of a single company, or ownership of 5% or more of the total shares of a single company
  3. Patent royalties from a company or for-profit organization: income of ¥1 million or more for 1 year in royalties for a single patent
  4. Honoraria (lecture fee, etc.) paid by a company or for-profit organization as compensation for time/labor devoted to attendance (presentation) at a conference: income totaling ¥500,000 or more for 1 year from any single company or organization
  5. Manuscript fees for pamphlets, etc., paid by a company or for-profit organization: income totaling ¥500,000 or more for 1 year from any single company or organization
  6. Grants/research funds (commissioned research funding, research grants, etc.) and endowed chairs provided by a company or for-profit organization: commissioned or joint research funding related to the presentation topic totaling ¥2 million for 1 year from any single company; research grants awarded to you or the leader of the section (chair, field) or research lab to which you belong totaling ¥2 million for 1 year from any single company or other organization; cases in which you occupy a chair endowed by a company or other organization
  7. Other remuneration (travel expenses, gifts, etc. not directly related to research): income totaling ¥50,000 or more for 1 year from any single company or other organization
Disclosure method

For oral session, include a self-disclosure of the state of COI in the second slide (following the title slide).
Sample slides are available here.

Ethical Consideration

All human and animal studies must have been approved by the authors’ institutional review board. All clinical investigation must have been conducted according to Declaration of Helsinki principles. Keep subjects’ personal information confidential.

Young Investigators Award(YIA)

This award is open to individuals aged 40 or younger as of the end of the 2025 fiscal year (March 2026).
To apply for this award, please check the “Young Investigators Award (YIA)” box in the Abstract Submission Format and clearly state your date of birth.
Presentations will be made at the YIA session on the day of the academic conference, and recipients will be selected based on the evaluation of those presentations.

Submission Procedures

Download the “Abstract Submission Format (docx)” below and fill in the required information.
Submit the completed format via email to the Congress Secretariat (11jpcphs@m-qol.co.jp).

Reviewing Result

We will send acceptance/rejection notifications to the email address provided at the time of abstract submission between late March and early April.

For inquiries

Congress Secretariat
E-mail: 11jpcphs@m-qol.co.jp